The Mediator Release Test (MRT) Leap 176 is an advanced diagnostic tool designed to identify individualized food and chemical sensitivities. Unlike traditional food sensitivity tests that rely on antibody detection, the MRT Leap 176 assesses changes in white blood cells in response to various foods and chemicals. This unique approach allows for the detection of sensitivities that may go unnoticed by other testing methods.
The test involves a simple blood draw, where a small amount of your white blood cells and plasma is exposed to 176 different foods and food chemicals, including common triggers like dairy, gluten, soy, as well as various fruits, vegetables, meats, and additives. The MRT measures the volume changes in blood cells, which indicates the release of inflammatory mediators when cells react to specific substances. These changes help identify foods and chemicals that trigger immune responses, potentially leading to inflammation and symptoms such as digestive issues, migraines, joint pain, and skin problems.
The MRT Leap 176 is particularly beneficial for individuals experiencing symptoms that suggest food sensitivities but have not been diagnosed with a food allergy. Since it provides a personalized profile of food sensitivities, it can be instrumental in developing tailored strategies to manage symptoms and enhance overall well-being. However, it is essential to consult with a healthcare provider before undergoing the MRT to ensure it is appropriate for your specific health situation. It is also important to note that while the MRT offers insights into potential food sensitivities, its clinical validity and standardization have been questioned by some experts, and more research is needed to fully establish its effectiveness.